InsiderFlow

OKYO

OKYO Pharma Limited$1.35-0.05 (-3.57%)
Prev Close$1.40·MCap$69.3M·P/E·Vol65.5K·Yield

Buys (12M)

6

$136.0K

Sells (12M)

0

$0.00

Net Activity

Net Buyer

$136.0K

Active Insiders

6

last 12 mo

Over the past 12 months, insider activity at OKYO Pharma Limited (OKYO) has been exclusively buying, with 6 insider purchases totaling $136.0K and 0 insider sales totaling $0.00. The most recent insider transaction was by JACOB GARY S (director, officer: CHIEF DEVELOPMENT OFFICER), who purchased $4.9K worth of shares on Aug 7, 2026. OKYO Pharma Limited operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $69.3M.

OKYO Insider Trading Activity

DateInsiderTypeValue
Aug 7, 2026 JACOB GARY SBuy$4.9K
Aug 7, 2026 Mantelli FlavioBuy$28.0K
Aug 7, 2026 Patil Rajkumar V.Buy$5.0K
Aug 7, 2026 BRANCACCIO JOHN PBuy$7.4K
Aug 7, 2026 CERRONE GABRIELE MBuy$67.6K
Aug 7, 2026 Dempsey Robert JohnBuy$23.1K

OKYO Insider Buying Activity

The following table shows recent insider purchases of OKYO Pharma Limited (OKYO) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Aug 7, 2026 JACOB GARY SBuy$4.9K
Aug 7, 2026 Mantelli FlavioBuy$28.0K
Aug 7, 2026 Patil Rajkumar V.Buy$5.0K
Aug 7, 2026 BRANCACCIO JOHN PBuy$7.4K
Aug 7, 2026 CERRONE GABRIELE MBuy$67.6K
Aug 7, 2026 Dempsey Robert JohnBuy$23.1K

OKYO Insider Selling Activity

The following table shows recent insider sales of OKYO Pharma Limited (OKYO) stock reported via SEC Form 4 filings.

No insider selling activity found for OKYO in the last 12 months.

OKYO Insiders

CERRONE GABRIELE M

director, 10 percent owner:

Bought $67.6K
1 tradesLast: Aug 7, 2026
JACOB GARY S

director, officer: CHIEF DEVELOPMENT OFFICER

Bought $4.9K
1 tradesLast: Aug 7, 2026
Mantelli Flavio

officer: CHIEF MEDICAL OFFICER

Bought $28.0K
1 tradesLast: Aug 7, 2026
BRANCACCIO JOHN P

director

Bought $7.4K
1 tradesLast: Aug 7, 2026
Dempsey Robert John

director, officer: CHIEF EXECUTIVE OFFICER

Bought $23.1K
1 tradesLast: Aug 7, 2026
Patil Rajkumar V.

officer: Chief Scientific Officer

Bought $5.0K
1 tradesLast: Aug 7, 2026